Q: Hi Peter & team,
I am curious about your thoughts with regards to MindMed (MNMD). They are a US biotech that is involved with clinically supervised psychedelic therapy for PTSD, anxiety, etc.
Promising research has come out of Johns Hopkins led by Roland Griffiths. Public trust still needs to be ascertained, however, even if trust seems to be waning slowly with conventional medicine.
Would this be a holding that you expect to do well in the long term?
Any other non-conventional biotech firms that show promise?
Thank you!
Regards,
Andrew M.
I am curious about your thoughts with regards to MindMed (MNMD). They are a US biotech that is involved with clinically supervised psychedelic therapy for PTSD, anxiety, etc.
Promising research has come out of Johns Hopkins led by Roland Griffiths. Public trust still needs to be ascertained, however, even if trust seems to be waning slowly with conventional medicine.
Would this be a holding that you expect to do well in the long term?
Any other non-conventional biotech firms that show promise?
Thank you!
Regards,
Andrew M.